Histotripsy offers a new noninvasive ultrasound treatment for liver cancer

Histotripsy, a noninvasive ultrasound treatment for liver cancer, is gaining traction as a new option for patients. This FDA-cleared technique uses focused ultrasound pulses to mechanically destroy tumor tissue, offering a potential alternative to thermal ablation methods. Radiologists are evaluating its clinical evidence, patient selection criteria, and its emerging role alongside existing cancer therapies.